Grantham, Mayo, Van Otterloo & Co (GMO)’s Meredith Corporation MDP Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio MDP Stock Details MDP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-5,300	Closed	-$350K	–	646
2017 Q4	$350K	Sell	5,300 -26,385	-83%	-$1.59M	﹤0.01%	497
2017 Q3	$1.76M	Buy	31,685 +2,300	+8%	+$130K	0.01%	335
2017 Q2	$1.75M	Sell	29,385 -2,500	-8%	-$146K	0.01%	326
2017 Q1	$2.06M	Sell	31,885 -1,738	-5%	-$107K	0.01%	321
2016 Q4	$1.99M	Sell	33,623 -10,391	-24%	-$545K	0.01%	320
2016 Q3	$2.29M	Sell	44,014 -38,071	-46%	-$2.03M	0.01%	320
2016 Q2	$4.26M	Buy	82,085 +48,485	+144%	+$2.4M	0.02%	308
2016 Q1	$1.6M	Buy	33,600 +3,700	+12%	+$157K	0.01%	387
2015 Q4	$1.29M	Sell	29,900 -327,200	-92%	-$14.7M	﹤0.01%	376
2015 Q3	$15.2M	Buy	+357,100	New	+$17M	0.05%	162
2014 Q1	–	Sell	-6,876	Closed	-$356K	–	666
2013 Q4	$356K	Sell	6,876 -1,230	-15%	-$62.8K	﹤0.01%	605
2013 Q3	$386K	Sell	8,106 -1,977	-20%	-$91.7K	﹤0.01%	591
2013 Q2	$481K	Buy	+10,083	New	+$414K	﹤0.01%	541

Other funds holding MDP

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

CVA

Ceredex Value Advisors Orlando, Florida $3.18B AUM 35.23% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Fairpointe Capital Chicago, Illinois $66.3M AUM 101.32% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO)'s MDP Position: Q1 2018 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of Meredith Corporation (MDP) in Q1 2018, closing a stake of 5,300 shares — an estimated $350K sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in MDP in Q2 2013 and held it in 13 quarters. The position peaked at $15.2M in Q3 2015. 257 funds tracked by Wall St. Rank hold MDP as of Q1 2018.

Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining Meredith Corporation position as of Q1 2018 after selling out during the quarter.
Grantham, Mayo, Van Otterloo & Co (GMO) sold 5,300 Meredith Corporation shares in Q1 2018, an estimated $350K.
Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Meredith Corporation in Q2 2013 and held it in 13 quarters.
Grantham, Mayo, Van Otterloo & Co (GMO)'s Meredith Corporation position peaked at $15.2M in Q3 2015.
257 funds tracked by Wall St. Rank held Meredith Corporation as of Q1 2018.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q1 2018, filed 15 May 2018.